Top 100 (of 508) individual protein antibodies significantly different after glucosamine and chondroitin supplementation versus placebo intervention periods (n = 18).

1Indicates that protein was in the GO (Gene Ontology) or KEGG (Kyoto Encyclopedia of Genes and Genomes) Cytokines pathway2Information pertaining to function is derived from PubMed Gene and/or UniProtKB unless otherwise noted3Values >1 indicate greater antibody expression after supplementation with G&C compared to placebo; values *All proteins listed were statistically significant with Bonferroni correction (P -5)Top 100 (of 508) individual protein antibodies significantly different after glucosamine and chondroitin supplementation versus placebo intervention periods (n = 18).1. 该标注表示对应蛋白质隶属于基因本体（Gene Ontology, GO）或京都基因与基因组百科全书（Kyoto Encyclopedia of Genes and Genomes, KEGG）细胞因子通路。2. 除非另有说明，相关功能信息均源自PubMed Gene数据库及/或UniProtKB数据库。3. 数值大于1代表补充G&C（葡萄糖胺与软骨素）后，抗体表达水平较安慰剂组更高；所有列示蛋白质均经邦费罗尼校正（P < 10⁻⁵），具有统计学显著性。本数据集共纳入508种单一蛋白质抗体，即为其中在氨基葡萄糖与软骨素补充干预周期与安慰剂干预周期（n=18）下表达存在显著差异的前100种蛋白质抗体。